Canada

Synonyms: 
canadian
canuck
ontario
newfoundland
PEI
nova scotia
new brunswick
quebec
manitoba
sasketchewan
alberta
BC
Mon
30
Mar

Hemp Based Batteries Could Change The Way We Store Energy Forever

As hemp makes a comeback in the U.S. after a decades-long ban on its cultivation, scientists are reporting that fibers from the plant can pack as much energy and power as graphene, long-touted as the model material for supercapacitors. They’re presenting their research, which a Canadian start-up company is working on scaling up, at the 248th National Meeting & Exposition of the American Chemical Society (ACS), the world’s largest scientific society.

Although hemp (cannabis sativa) and marijuana (cannabis sativa var. indica) come from a similar species of plant, they are very different and confusion has been caused by deliberate misinformation with far reaching effects on socioeconomics as well as on environmental matters.

Fri
27
Mar

Ups and Downs In the Canadian MMJ Industry

New regulations in Canada designed to improve access to higher quality medical cannabis have shaken up the market.

The rules have left some patients with few options to purchase and consume their medication, leading to several lawsuits. Meanwhile, the licensed cultivators and sellers who are now responsible for supplying safe, tested cannabis are laying down expansion plans amid optimistic growth forecasts.

Canada legalized medical marijuana on a federal level 15 years ago, and last year put in place new regulations that have smoothed the road for marijuana entrepreneurs. The path, however, has been a bumpy one, and further uncertainty looms on the horizon.

New Regulations Gives Boost to Licensed Operators

Thu
26
Mar

OSC probing marijuana firm CEN Biotech

CEN Biotech, a company that soared to be worth hundreds of millions of dollars last year on claims that it was being licensed to build the world’s largest medical marijuana facility in Canada, is under investigation by the Ontario Securities Commission.

The regulator said Wednesday it is looking into the company and its parent firm, but did not provide further details, such as how long the investigation has been going on or if regulators in the United States are involved.

“The OSC has an active investigation into this matter,” Carolyn Shaw-Rimmington, spokeswoman for the OSC, said in an e-mail to The Globe and Mail.

Thu
26
Mar

Medical Marijuana Update: MMJ phase II begins as C.NSP, C.SUN enter edibles space

The stock is a daytrade superstar, but also consistently moving up in price as speculators who see the potential for a big payday when the American listing hits (reportedly within four weeks) load up, and long holders who feel the edibles market is a big undeveloped MMJ play join in.
 
Nutritional High, right now anyway, is the perfect storm.
 
Will it deliver big revenues in two years? Don’t know. And, frankly, right now I don’t care. What I care about a lot is, is the thing likely to be higher tomorrow than it is today? And will it ramp up for the next month while it’s still a private Canadian investor club?
 

Thu
26
Mar

Tweed Marijuana Inc. Announces Partial Exercise of Over-Allotment Option by Underwriters

SMITHS FALLS, ON , March 25, 2015 /CNW/ - Tweed Marijuana Inc. ("Tweed") (TWD.V), is pleased to announce that the underwriters of Tweed's bought deal offering that closed on March 17, 2015 (the "Offering") have exercised their over-allotment option in part to purchase an additional 795,360 common shares of Tweed ("Common Shares") at a price of $2.15 per Common Share for gross proceeds to Tweed of $1,710,024 (the "Over-Allotment Offering"). The partial exercise of the over-allotment option closed today. 

Thu
26
Mar

"Farm to Pharma": MMJ Bioscience Inc. and ASX-Listed PhytoTech to Merge

Creating the First Global, Vertically-Integrated Medical Cannabis ("MC") Company

Highlights

Tue
24
Mar

Bacteria in bud prompts B.C. medical marijuana firm to recall product

OTTAWA – Hundreds of medical marijuana users in British Columbia have been told the pot they thought could help them might harm them because it’s contaminated with bacteria.

Health Canada says Tilray, a Nanaimo supplier, is telling clients to stop using its Sativa House Blend, Hybrid House Blend and Indica House Blend.

The pot was contaminated with enterobacter, which is not associated with an acute health risk, said Joshua Eades, Tilray’s chief science officer.

He said the company doesn’t know where the bacteria originated.

“We are undergoing a top-to-bottom, rigorous review of our sanitation practices and procedures,” he said. “And we’ll be doing a root-cause analysis to understand what caused these results.”

Tue
24
Mar

Seeking the Facts on Medical Marijuana

­Dr. Mark Ware, with a marijuana leaf image projected on his hand, is the director of the Canadian Consortium for the Investigation of Cannabinoids. March 23, 2015 Claudia Dreifus A CONVERSATION WITH

Twenty-three states and the District of Columbia have legalized medical marijuana, but scientific research into its appropriate uses has lagged. Dr. Mark Ware would like to change that.

Dr. Ware, 50, is the director of the Canadian Consortium for the Investigation of Cannabinoids and the director of clinical research of the Alan Edwards Pain Management Unit of McGill University Health Center. Medical marijuana has been legal in Canada for 16 years, and Dr. Ware, a practicing physician, studies how his patients take the drug and under what conditions it is effective.

Mon
23
Mar

Recall of Marijuana for Medical Purposes - Tilray

Tilray is voluntarily recalling three marijuana for medical purposes products due to positive bacterial testing: Sativa House Blend (Lot number: 5411 9952 8740 9514), Hybrid House Blend (Lot number: 6889 8271 1515 4149) and Indica House Blend (Lot number: 3470 2895 9118 1906).

During the course of a regular inspection conducted under the Marihuana for Medical Purposes Regulations, Health Canada inspectors tested the above products to ensure compliance with the regulation.

Tilray’s clients should consult with a healthcare professional if they have concerns about their health related to the use of this product.

Mon
23
Mar

Medical Marijuana for Canadian Injured Vets Cost Government $4.3M

The cost of providing medical marijuana to the country's injured soldiers under a Veterans Affairs program jumped to more than $4.3 million this fiscal year, an increase of 10 times what was spent last year.

And the number of ex-soldiers eligible for taxpayer-funded, prescribed pot more than quadrupled to 601 patients, according to figures released by the department.

The numbers represent a dramatic escalation, even from last fall, when former veterans minister Julian Fantino was told in a briefing note that there were 224 approved cases.

At the beginning of the last budget year there were 116 eligible veterans.

Pages

Subscribe to RSS - Canada